Viking Therapeutics Inc (VKTX)
54.68
-0.36
(-0.65%)
USD |
NASDAQ |
Nov 14, 11:41
Viking Therapeutics Total Return Level: 55.04 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 55.04 |
November 12, 2024 | 60.60 |
November 11, 2024 | 62.97 |
November 08, 2024 | 68.48 |
November 07, 2024 | 68.85 |
November 06, 2024 | 65.87 |
November 05, 2024 | 64.63 |
November 04, 2024 | 63.14 |
November 01, 2024 | 72.88 |
October 31, 2024 | 72.54 |
October 30, 2024 | 71.75 |
October 29, 2024 | 73.35 |
October 28, 2024 | 74.52 |
October 25, 2024 | 78.03 |
October 24, 2024 | 73.22 |
October 23, 2024 | 60.39 |
October 22, 2024 | 62.03 |
October 21, 2024 | 64.34 |
October 18, 2024 | 65.80 |
October 17, 2024 | 64.62 |
October 16, 2024 | 65.85 |
October 15, 2024 | 65.38 |
October 14, 2024 | 65.80 |
October 11, 2024 | 65.84 |
October 10, 2024 | 62.45 |
Date | Value |
---|---|
October 09, 2024 | 62.64 |
October 08, 2024 | 66.68 |
October 07, 2024 | 63.01 |
October 04, 2024 | 64.96 |
October 03, 2024 | 64.11 |
October 02, 2024 | 64.69 |
October 01, 2024 | 62.00 |
September 30, 2024 | 63.31 |
September 27, 2024 | 61.63 |
September 26, 2024 | 62.32 |
September 25, 2024 | 63.13 |
September 24, 2024 | 61.93 |
September 23, 2024 | 65.01 |
September 20, 2024 | 70.47 |
September 19, 2024 | 68.16 |
September 18, 2024 | 64.45 |
September 17, 2024 | 62.94 |
September 16, 2024 | 67.10 |
September 13, 2024 | 66.73 |
September 12, 2024 | 62.81 |
September 11, 2024 | 60.83 |
September 10, 2024 | 54.65 |
September 09, 2024 | 54.78 |
September 06, 2024 | 54.13 |
September 05, 2024 | 55.39 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.11
Minimum
Jun 16 2022
94.50
Maximum
Feb 28 2024
16.44
Average
6.825
Median
Total Return Level Benchmarks
Amgen Inc | 425.02 |
Eli Lilly and Co | 2343.87 |
Pfizer Inc | 95.41 |
Structure Therapeutics Inc | 36.37 |
Altimmune Inc | 17.90 |